EUVIMEDEUVIMED entdecken
Crossref

Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk

Emily Harris

JAMA · 2024

DOI: 10.1001/jama.2024.5922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Anticonvulsants, Autistic Disorder, Epilepsy, Prenatal Exposure Delayed Effects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsAutistic DisorderEpilepsyPrenatal Exposure Delayed EffectsValproic AcidChildFemaleHumansPregnancyPregnancy ComplicationsRiskTopiramateLamotrigine

Substanzen

AnticonvulsantsValproic AcidTopiramateLamotrigine

Zitieren

APA

Harris, E. (2024). Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk. JAMA. https://doi.org/10.1001/jama.2024.5922

Vancouver

Harris E. Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk. JAMA. 2024. doi:10.1001/jama.2024.5922

BibTeX
@article{Harris2024,
  author = {Harris, Emily},
  title = {Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.5922}
}
Kostenlos starten →